CD4 and rheumatoid arthritis: A study evaluated the effect of MTX treatment on the percentage and absolute number of CD4+Foxp3+ Tregs in the peripheral blood of untreated patients with early-stage RA and found that increases and phenotypic changes in Treg cells were associated with MTX treatment closely (109).